Functionalized bimagnetic core/shell FE/FE3O4 stealth nanoparticles for diagnosis & treatment of cancer
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201000111C
- Awardee
-
Nanoscale Corporation UEI K2MGCFK6SAE9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $831,900
Award facts
- Contract value 100% obligated
- $831,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Manhattan, KS 66502, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Default | -$168,100 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,000,000 |
About this award
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the University of Kansas Medical Center Research Institute, Inc., which will evaluate the nanoparticles in an ex vivo tumor model and assist with clinical trial design. The contract is focused on advancing this novel nanoparticle technology from the preclinical stage towards potential clinical applications in cancer management.
Quick answers
Who was awarded contract HHSN261201000111C?
HHSN261201000111C was awarded to Nanoscale Corporation by National Cancer Institute (National Institutes of Health) on September 30, 2010.
How much is contract HHSN261201000111C worth?
The government has obligated $831,900 on HHSN261201000111C.
Was contract HHSN261201000111C competed?
The extent of competition for HHSN261201000111C was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award